The content is available as a PDF (95.0 KB).
letter . 2020 May 16:hcaa173. doi: 10.1093/qjmed/hcaa173
Reply: Use of statins in patients with COVID-19
Mark R Goldstein
h1,✉, Gregory A Poland
h2, Charles W Graeber
h3
Mark R Goldstein, MD, FACP
h1
NCH Physician Group, Center for Healthy Living, 132 Moorings Park Drive, Naples, FL, USA
Find articles by Mark R Goldstein
Gregory A Poland, MD, MACP, FIDSA, FRCP (London)
h2Mary Lowell Leary Emeritus Professor of Medicine, USA, Distinguished Investigator of the Mayo Clinic, USA, Director, Mayo Vaccine Research Group, USA, Editor-in-Chief, VACCINE, 611C Guggenheim Building, Mayo Clinic and Foundation, Rochester, MN, USA
Find articles by Gregory A Poland
Charles W Graeber, MD
h3Adjunct Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science, Professor of Internal Medicine, University of Central Florida, College of Medicine. Program Director, NCH Healthcare System Internal Medicine Residency, Affiliate of the Mayo Clinic School of Medicine and Science, Naples, FL, USA
Find articles by Charles W Graeber
h1
NCH Physician Group, Center for Healthy Living, 132 Moorings Park Drive, Naples, FL, USA
h2Mary Lowell Leary Emeritus Professor of Medicine, USA, Distinguished Investigator of the Mayo Clinic, USA, Director, Mayo Vaccine Research Group, USA, Editor-in-Chief, VACCINE, 611C Guggenheim Building, Mayo Clinic and Foundation, Rochester, MN, USA
h3Adjunct Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science, Professor of Internal Medicine, University of Central Florida, College of Medicine. Program Director, NCH Healthcare System Internal Medicine Residency, Affiliate of the Mayo Clinic School of Medicine and Science, Naples, FL, USA
✉
Corresponding Author: Email: markrgoldstein@comcast.net, Phone: 239.624.1120
Received 2020 May 8; Accepted 2020 May 11.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7239152 PMID: 32415962
See "Use of statins in patients with COVID-19", hcaa172.